Nihon Kohden (OTCMKTS:NHNKY) Share Price Crosses Above 200 Day Moving Average – Time to Sell?

Posted by Stanley Muller on Oct 28th, 2026

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $9.85 and traded as high as $10.53. Nihon Kohden shares last traded at $10.1150, with a volume of 12,338 shares changing hands.

Analysts Set New Price Targets

Separately, UBS Group lowered Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, Nihon Kohden presently has an average rating of “Hold”.

View Our Latest Research Report on Nihon Kohden

Nihon Kohden Trading Down 1.0%

The stock has a market cap of $1.68 billion, a PE ratio of 18.21 and a beta of 0.38. The firm has a 50-day simple moving average of $9.96 and a 200-day simple moving average of $9.84. The company has a quick ratio of 2.64, a current ratio of 3.98 and a debt-to-equity ratio of 0.12.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.09). Nihon Kohden had a net margin of 5.90% and a return on equity of 9.17%. The company had revenue of $297.47 million during the quarter, compared to analysts’ expectations of $299.98 million. Equities analysts forecast that Nihon Kohden Corporation will post 0.60 earnings per share for the current year.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and markets electronic medical equipment and related solutions. Founded in 1951 and headquartered in Tokyo, the company serves hospitals, clinics and other healthcare providers through operations in Japan and international markets.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs and other neurological diagnostic equipment. Nihon Kohden also supplies defibrillators, automated external defibrillators, ventilators, anesthesia-related equipment, clinical information systems and devices used in in-vitro diagnostics, including hematology testing.

The company distributes its products through domestic and overseas subsidiaries, distributors and service networks.